- Home
- IART vs OMCL Comparison
IART vs OMCL Comparison
Compare IART & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IART
- OMCL
- Stock Information
- Founded
- IART 1989
- OMCL 1992
- Country
- IART United States
- OMCL United States
- Employees
- IART N/A
- OMCL N/A
- Industry
- IART Medical/Dental Instruments
- OMCL Computer Manufacturing
- Sector
- IART Health Care
- OMCL Technology
- Exchange
- IART Nasdaq
- OMCL Nasdaq
- Market Cap
- IART 1.7B
- OMCL 1.8B
- IPO Year
- IART 1995
- OMCL 2001
- Fundamental
- Price
- IART $21.13
- OMCL $39.72
- Analyst Decision
- IART Sell
- OMCL Buy
- Analyst Count
- IART 7
- OMCL 6
- Target Price
- IART $24.67
- OMCL $52.33
- AVG Volume (30 Days)
- IART 507.2K
- OMCL 455.8K
- Earning Date
- IART 02-25-2025
- OMCL 02-06-2025
- Dividend Yield
- IART N/A
- OMCL N/A
- EPS Growth
- IART N/A
- OMCL N/A
- EPS
- IART N/A
- OMCL 0.27
- Revenue
- IART $1,564,920,000.00
- OMCL $1,112,238,000.00
- Revenue This Year
- IART $6.71
- OMCL $4.02
- Revenue Next Year
- IART $6.20
- OMCL $4.32
- P/E Ratio
- IART N/A
- OMCL $147.11
- Revenue Growth
- IART 1.45
- OMCL N/A
- 52 Week Low
- IART $16.81
- OMCL $25.12
- 52 Week High
- IART $45.09
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- IART 27.91
- OMCL 38.90
- Support Level
- IART $23.67
- OMCL $39.23
- Resistance Level
- IART $24.69
- OMCL $40.50
- Average True Range (ATR)
- IART 0.89
- OMCL 2.04
- MACD
- IART -0.57
- OMCL -0.21
- Stochastic Oscillator
- IART 0.68
- OMCL 14.21
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.